Model Information:
High‑grade carcinoma originating in the adrenal region with local extension into adjacent soft tissue; immunohistochemistry supportive of neuroendocrine differentiation.
Request a Custom Quote for XA3001 Xenograft ModelSummary:
| Category | Parameter | Model Detail (XA3001) |
| Identity | Model ID | XA3001 |
| Cancer Type | Adrenal Gland Cancer | |
| Model Type | PDX (Patient-Derived Xenograft) | |
| Clinical Background | Patient Age | 54 |
| Patient Gender | Male | |
| Ethnicity | N/A | |
| Diagnosis | High-grade Adrenal Carcinoma (Neuroendocrine differentiation) | |
| Stage | Locally Advanced (Soft Tissue Extension) | |
| Sample Site | Adrenal Mass | |
| Genomics & Biomarkers | Primary Driver | Neuroendocrine Markers (Chromogranin A/Synaptophysin+) |
| Cytogenetics | N/A | |
| WES (Whole Exome) | N/A | |
| RNA-Seq | N/A | |
| CNV Profile | N/A | |
| Mutational Load | N/A | |
| Characterization | Surface Markers | NCAM+, SF-1+, Ki-67 (High) |
| Host Strain | NSG (NOD scid gamma) | |
| Inoculation Route | Subcutaneous | |
| Growth Kinetic | N/A | |
| Pharmacology | SoC Response | N/A |
| Immune Profiling | N/A |
Growth Characteristics:
